120 related articles for article (PubMed ID: 30094907)
1. Acquired ornithine transcarbamylase deficiency in pediatric and adolescent patients with fibrolamellar hepatocellular carcinoma.
Bartlett AL; Leslie ND; Gupta A; Geller JI
Pediatr Blood Cancer; 2018 Dec; 65(12):e27392. PubMed ID: 30094907
[TBL] [Abstract][Full Text] [Related]
2. A Proposed Physiopathological Pathway to Hyperammonemic Encephalopathy in a Non-Cirrhotic Patient with Fibrolamellar Hepatocellular Carcinoma without Ornithine Transcarbamylase (OTC) Mutation.
Surjan RC; Dos Santos ES; Basseres T; Makdissi FF; Machado MA
Am J Case Rep; 2017 Mar; 18():234-241. PubMed ID: 28270654
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinoma in a research subject with ornithine transcarbamylase deficiency.
Wilson JM; Shchelochkov OA; Gallagher RC; Batshaw ML
Mol Genet Metab; 2012 Feb; 105(2):263-5. PubMed ID: 22129577
[TBL] [Abstract][Full Text] [Related]
4. Hyperammonemic Encephalopathy Mimicking Ornithine Transcarbamylase Deficiency in Fibrolamellar Hepatocellular Carcinoma: Successful Treatment with Continuous Venovenous Hemofiltration and Ammonia Scavengers.
Lee JS; Jin HY; Ko JM; Kim SH; Han N; Park BK; Park M; Park HJ; Lee JA
Cancer Res Treat; 2021 Jan; 53(1):283-288. PubMed ID: 32898940
[TBL] [Abstract][Full Text] [Related]
5. Hyperammonemic Encephalopathy Associated With Fibrolamellar Hepatocellular Carcinoma: Case Report, Literature Review, and Proposed Treatment Algorithm.
Chapuy CI; Sahai I; Sharma R; Zhu AX; Kozyreva ON
Oncologist; 2016 Apr; 21(4):514-20. PubMed ID: 26975868
[TBL] [Abstract][Full Text] [Related]
6. Refractory Hyperammonemic encephalopathy in Fibrolamellar hepatocellular carcinoma, a case report and literature review.
Ahmed A; Ata F; Gaber M; Petkar M; Mahfouz A; Schirmacher P; Musa S; Hashim A
Curr Probl Cancer; 2022 Jun; 46(3):100847. PubMed ID: 35276469
[TBL] [Abstract][Full Text] [Related]
7. Ornithine transcarbamylase and arginase I deficiency are responsible for diminished urea cycle function in the human hepatoblastoma cell line HepG2.
Mavri-Damelin D; Eaton S; Damelin LH; Rees M; Hodgson HJ; Selden C
Int J Biochem Cell Biol; 2007; 39(3):555-64. PubMed ID: 17098461
[TBL] [Abstract][Full Text] [Related]
8. [Fibrolamellar hepatocellular carcinoma: a clinical report with paraneoplastic hyperthyroidism (apropos of a case)].
Carri J; Peral F; Surreco M; Luján A; Leguizamón R; Martínez G; Salvucci M
Acta Gastroenterol Latinoam; 1989; 19(3):155-64. PubMed ID: 2561432
[TBL] [Abstract][Full Text] [Related]
9. Prenatal treatment of ornithine transcarbamylase deficiency.
Wilnai Y; Blumenfeld YJ; Cusmano K; Hintz SR; Alcorn D; Benitz WE; Berquist WE; Bernstein JA; Castillo RO; Concepcion W; Cowan TM; Cox KL; Lyell DJ; Esquivel CO; Homeyer M; Hudgins L; Hurwitz M; Palma JP; Schelley S; Akula VP; Summar ML; Enns GM
Mol Genet Metab; 2018 Mar; 123(3):297-300. PubMed ID: 29396029
[TBL] [Abstract][Full Text] [Related]
10. Activity of the liver enzyme ornithine carbamoyltransferase (OTC) in blood: LC-MS/MS assay for non-invasive diagnosis of ornithine carbamoyltransferase deficiency.
Krijt J; Sokolová J; Ješina P; Dvořáková L; Řeboun M; Brennerová K; Mistrík M; Zeman J; Honzík T; Kožich V
Clin Chem Lab Med; 2017 Jul; 55(8):1168-1177. PubMed ID: 28107167
[TBL] [Abstract][Full Text] [Related]
11. Ratio of serum ornithine carbamoyltransferase to alanine aminotransferase as a potent indicator for hepatocellular carcinoma.
Murayama H; Fukuda Y; Tsunekawa S; Ikemoto M; Nagata A
Clin Biochem; 2007 Sep; 40(13-14):1077-80. PubMed ID: 17570354
[TBL] [Abstract][Full Text] [Related]
12. Hyperammonemic encephalopathy: a rare presentation of fibrolamellar hepatocellular carcinoma.
Sethi S; Tageja N; Singh J; Arabi H; Dave M; Badheka A; Revankar S
Am J Med Sci; 2009 Dec; 338(6):522-4. PubMed ID: 20010160
[TBL] [Abstract][Full Text] [Related]
13. Postchemotherapy hyperammonemic encephalopathy emulating ornithine transcarbamoylase (OTC) deficiency.
Chan JS; Harding CO; Blanke CD
South Med J; 2008 May; 101(5):543-5. PubMed ID: 18414167
[TBL] [Abstract][Full Text] [Related]
14. Fibrolamellar variant of hepatocellular carcinoma does not have a better survival than conventional hepatocellular carcinoma--results and treatment recommendations from the Childhood Liver Tumour Strategy Group (SIOPEL) experience.
Weeda VB; Murawski M; McCabe AJ; Maibach R; Brugières L; Roebuck D; Fabre M; Zimmermann A; Otte JB; Sullivan M; Perilongo G; Childs M; Brock P; Zsíros J; Plaschkes J; Czauderna P; Aronson DC
Eur J Cancer; 2013 Aug; 49(12):2698-704. PubMed ID: 23683550
[TBL] [Abstract][Full Text] [Related]
15. Thrombocytosis: a paraneoplastic syndrome in patients with hepatocellular carcinoma.
Hwang SJ; Luo JC; Li CP; Chu CW; Wu JC; Lai CR; Chiang JH; Chau GY; Lui WY; Lee CC; Chang FY; Lee SD
World J Gastroenterol; 2004 Sep; 10(17):2472-7. PubMed ID: 15300887
[TBL] [Abstract][Full Text] [Related]
16. Hyperammonemic encephalopathy in a child with ornithine transcarbamylase deficiency due to a novel combined heterozygous mutations.
Gao J; Gao F; Hong F; Yu H; Jiang P
Am J Emerg Med; 2015 Mar; 33(3):474.e1-3. PubMed ID: 25227973
[TBL] [Abstract][Full Text] [Related]
17. Hyperammonemia in ornithine transcarbamylase-deficient recipients following living donor liver transplantation from heterozygous carrier donors.
Rahayatri TH; Uchida H; Sasaki K; Shigeta T; Hirata Y; Kanazawa H; Mali V; Fukuda A; Sakamoto S; Kasahara M
Pediatr Transplant; 2017 Feb; 21(1):. PubMed ID: 27891735
[TBL] [Abstract][Full Text] [Related]
18. Significant hepatic involvement in patients with ornithine transcarbamylase deficiency.
Gallagher RC; Lam C; Wong D; Cederbaum S; Sokol RJ
J Pediatr; 2014 Apr; 164(4):720-725.e6. PubMed ID: 24485820
[TBL] [Abstract][Full Text] [Related]
19. A new mouse model of mild ornithine transcarbamylase deficiency (spf-j) displays cerebral amino acid perturbations at baseline and upon systemic immune activation.
Tarasenko TN; Rosas OR; Singh LN; Kristaponis K; Vernon H; McGuire PJ
PLoS One; 2015; 10(2):e0116594. PubMed ID: 25647322
[TBL] [Abstract][Full Text] [Related]
20. [Ornithine-carbamoyl-transferase and its clinical valve].
Labadie P
Rev Prat; 1972 Apr; 22(12):2001-9. PubMed ID: 4345933
[No Abstract] [Full Text] [Related]
[Next] [New Search]
